Article
CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants.
Journal of nanobiotechnology - 29 Apr 2023
Chen Zhi, Wu Chenshuo, Yuan Yuxuan, Xie Zhongjian, Li Tianzhong, Huang Hao, Li Shuang, Deng Jiefeng, Lin Huiling, Shi Zhe, Li Chaozhou, Hao Yabin, Tang Yuxuan, You Yuehua, Al-Hartomy Omar A, Wageh Swelm, Al-Sehemi Abdullah G, Lu Ruitao, Zhang Ling, Lin Xuechun, He Yaqing, Zhao Guojun, Li Defa, Zhang Han
Abstract excerpt
Since the end of 2019, a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has deprived numerous lives worldwide, called COVID-19. Up to date, omicron is the latest variant of concern, and BA.5 is replacing the BA.2 variant to become the main subtype rampaging worldwide. These subtypes harbor an L452R mutation, which increases their transmissibility among vaccinated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
